LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Alaunos Therapeutics, Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERTCRT
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / TCRT COVERAGE

What’s moving Alaunos Therapeutics, Inc. now

Current reporting with the operating signal separated from the noise.

01
TradingView

Enterprise value to EBIT forward of Alaunos Therapeutics, Inc. – NASDAQ:TCRT

The story matters when it changes Alaunos Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest TCRT filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-15 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-14 · Period 2025-09-30SEC ↗10-K/AAnnual financial reportFiled 2026-04-30 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-29 · Period 2026-06-29SEC ↗8-KMaterial company eventFiled 2026-05-26 · Period 2026-05-26SEC ↗8-KMaterial company eventFiled 2026-05-18 · Period 2026-05-18SEC ↗DEF 14AProxy and shareholder meetingFiled 2025-05-21 · Period 2025-07-03SEC ↗4Official SEC filingFiled 2026-07-27 · Period 2026-07-23SEC ↗
EARNINGS / QUARTERLY TRACKER

Alaunos Therapeutics, Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.